Chronic kidney disease (CKD) presents a significant clinical challenge for anticoagulation therapy due to the coexistence of elevated thromboembolic risk and increased bleeding tendency. Management is further complicated by altered pharmacokinetics, limited high-quality evidence in advanced CKD, and the systematic excl...
A. Soliman, S. El-Khashab, A. Fayed et al.· The Egyptian Journal of Inte...· 0 citations
The global prevalence of obesity continues to rise, with 3 billion adults projected to be affected by 2030. Recent advances in anti-obesity pharmacotherapy, particularly incretin-based medications, have transformed obesity management. This consensus provides evidence-based guidelines for the clinical use of incretin-ba...
Inass Shaltout, M. Hegazy, A. E. El Meligi et al.· The Egyptian Journal of Inte...· 0 citations
The future of nephrology will be defined not by a single disruptive innovation, but by the convergence of prevention, precision medicine, digital health, regenerative biology, and advanced kidney replacement technologies.
A. Soliman, A. Fayed, S. El-Khashab· International Urology and Ne...· 0 citations
This structured narrative review aims to synthesize current evidence, assess the relevance of aspirin as a low-cost, scalable intervention within diverse populations and critically evaluate recent guideline changes regarding primary prevention.
A. Soliman, Ahmed Fayed, Tasneem Halaby et al.· The Egyptian Journal of Inte...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
